Treatment of raised blood pressure in the population: the Canadian experience

Am J Hypertens. 1998 Jun;11(6 Pt 1):747-9. doi: 10.1016/s0895-7061(98)00067-3.


The Canadian Heart Health Survey, in which all 10 Canadian provinces participated using a standardized protocol, provides data from 23,129 randomly selected participants. The hypertension component of this survey indicates a prevalence of 22%; among these hypertensives, 59% were aware of their elevated blood pressure status. The breakdown of aware hypertensives indicates that 16% of those were treated and controlled, 24% were treated but not controlled, and 19% were neither treated nor controlled. In terms of drug prescription pattern, angiotensin converting enzyme inhibitors, including angiotensin II antagonists, command the maximum market share of 27.7% ($36 million), followed by diuretics, calcium channel blockers, beta3-blockers, and others. Although hypertension awareness and control have improved in the past 25 years, sustained efforts are warranted to control hypertension in Canada.

MeSH terms

  • Antihypertensive Agents / therapeutic use*
  • Blood Pressure / drug effects
  • Canada / epidemiology
  • Costs and Cost Analysis
  • Humans
  • Hypertension / drug therapy*
  • Hypertension / economics
  • Hypertension / epidemiology
  • Hypertension / physiopathology


  • Antihypertensive Agents